ArticleJournal of ophthalmic & vision research

Modification of a Selective NTRK2 Agonist and Confirmation of Activity in a Glaucoma-on-a-Chip Model.

Fatemeh Nafian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.